
Sarah Beckett Cleveland, PhD
I am honored and excited to be selected as a 2026-2027 AAI Public Policy Fellow. I am a PhD-trained immunologist with a background in T cell biology and autoimmune disease development, and an interest in how scientific discoveries translate into improved health outcomes. I believe scientists have a responsibility beyond the bench, particularly at a time when public trust in science, federal research funding, and evidence-based health policy face increasing challenges. Through the AAI PPFP, I look forward to gaining a deeper understanding of the federal policymaking process, strengthening my ability to communicate complex immunological concepts to diverse audiences, and learning how scientists can effectively advocate for evidence-based policy. I am eager to help ensure that scientific evidence remains central to public health decision-making. I am deeply grateful to AAI for this opportunity and for its continued commitment to engaging early-career scientists in science policy and advocacy.

Utsa Bhaduri, PhD
Harvard Medical School (Massachusetts)
I am deeply honored to receive the 2026–27 Public Policy Fellowship from AAI. As a postdoctoral research fellow at Harvard Medical School and in the Precision Vaccines Program at Boston Children’s Hospital, I conduct systems immunology and vaccinology research with a focus on immunometabolism in early human life. Born in India and trained for my PhD as a Marie Sk艂odowska-Curie Fellow in Italy and Europe, I experienced the COVID-19 pandemic across different societal and political contexts, revealing how policy decisions can amplify or undermine scientific advances. These experiences strengthened my commitment to working at the intersection of basic and translational immunology, public health, and policy. Through the fellowship, I hope to gain firsthand insight into how the U.S. Congress, the administration, and federal agencies shape policy and funding decisions that directly impact biomedical research and public health, while strengthening my ability to communicate complex scientific concepts to policymakers and the public.

Joseph Dolence, PhD
University of Nebraska at Kearney
I am honored to be selected as an AAI Public Policy Fellow for the 2026-2027 cohort. At a time when science funding, higher education, and public trust in biomedical research face significant challenges, it is essential for scientists to engage directly in policy conversations. As an immunologist who is a faculty leader at a primarily undergraduate institution in rural Nebraska, I see firsthand how federal and state decisions shape research programs, student opportunities, and the strength of our communities. Through this fellowship, I look forward to strengthening my ability to advocate effectively for sustained investment in biomedical research, science literacy, and higher education. I am especially eager to apply what I learn not only at the federal level, but also within Nebraska, where thoughtful advocacy can make a meaningful difference. I am incredibly grateful to AAI for this opportunity and look forward to working alongside fellow scientists to advance thoughtful, science-informed policy.
Matthew Fischer, PhD
Princeton University (New Jersey)
It’s a great honor to be selected to participate in AAI’s Public Policy Fellows Program. I am excited to learn about what makes an effective public policy, and the best strategies to advocate for scientific research. Scientists have a responsibility to clearly and effectively communicate their research to both scientific and non-scientific communities. In addition, I am looking forward to working with the policy experts within AAI to learn the best strategies to advocate for research to the public and empower us to be valuable resources for policy makers. The need for clear and concise scientific communication to the public has never been greater, and I hope that through this program I will develop skills for promoting the importance of basic immunological and clinical research. I am grateful for the opportunity to join this cohort to learn how to be effective mediators between elected officials and the scientific community.
Olanrewaju Morenikeji, PhD
Virginia State University
Being named an AAI Public Policy Fellow is a remarkable privilege and a significant milestone in my career. Although my primary responsibilities are at the laboratory bench, I recognize the duty of every scientist to participate in both the societal and political frameworks that support our research. I am excited to represent AAI and learn how to translate complex scientific concepts into compelling narratives for policymakers. I look forward to collaborating with fellow scientists to advance the importance of immunology and to ensure a robust future for the next generation of researchers through strategic advocacy and informed policy engagement.
Jacqueline (Koko) Mutai, PhD
Oregon Health and Science University
Kenya Medical Research Institute (KEMRI), Kenya
I am honored to have been selected as a fellow in the AAI Public Policy Fellowship Program (PPFP). As an African Scientist working at the intersection of immunology and vaccinology, this opportunity is particularly meaningful to me because it provides a platform to better understand how science policies in the Global North shape research priorities and public health outcomes in the Global South. Much of the funding and policy decisions that influence infectious disease research are made far from communities most affected. Through this fellowship, I hope to connect with public health policy fellows, raise awareness of the effects of funding decisions on low- and middle-income countries, strengthen my ability to communicate scientific evidence effectively to policymakers, and contribute to conversations that advance equitable global health.
Rachel Prescott, PhD
St. Jude Children’s Research Hospital (Tennessee)
I am thrilled to participate in the 2026-2027 AAI Public Policy Fellowship Program. As a researcher studying the host-microbe interactions of emerging pathogens, I have directly witnessed the importance of policy decisions both on the research community and public health as a whole. In my experience, many people both in both government and the wider populace are willing to learn about why science policy is important, but the availability of experts on these subjects who are willing to teach them is scarce and communicating these important ideas can often be difficult. I have always believed that we as scientists are at least partially responsible for communicating how important policy decisions around the scientific community can be, and I am excited to get to directly engage in the process and learn from policymakers through this program.
Christopher Risley, PhD
The University of Alabama at Birmingham
I am honored to have been selected as an AAI Public Policy Fellow for the 2026-2027 cycle. In a climate where disinformation and public mistrust in science are increasingly prevalent, it is crucial to have informed and dedicated scientists advocating on behalf of the scientific community. As scientists, we are trained to think critically to solve complex scientific problems; this program provides the unique opportunity to learn how to translate those skills into the domain of public policy. I am excited to learn about the inner workings of science policy, and, in doing so, become a stronger advocate for science. I look forward to honing my scientific communication skills and collaborating with my AAI colleagues to leverage our skills for the benefit of both the scientific community and the communities we serve.
Andrew Simonson, PhD
University of Pittsburgh School of Medicine (Pennsylvania)
I am honored to be selected as a participant in the 2026–2027 AAI Public Policy Fellows Program. I study the immunology of tuberculosis, a disease that has affected humanity for millennia and continues to cause substantial morbidity and mortality worldwide. Although biomedical science has experienced tremendous technological advancement, progress against infectious diseases rarely comes from a single breakthrough. Rather, improvements in global health outcomes reflect decades of sustained scientific investment and collaboration. As scientists, we have a responsibility to clearly communicate the significance of our work beyond the research community and maintain meaningful engagement with the public. I look forward to engaging with policymakers, strengthening my ability to communicate the importance of biomedical research to broader audiences, and supporting evidence-based decision-making.
Lauren Stewart Stafford, PhD
Case Western Reserve University School of Medicine (Ohio)
I am so honored to be selected as a 2026-2027 AAI Public Policy Fellow! My research focuses on how moms and babies respond to maternal vaccination, putting my work at an important intersection of immunology, public health, and women and infant health. Currently, we are living through a remarkable time in history where vaccinations have become increasingly controversial, placing neonates and infants at extreme risk. I truly believe we as scientists are necessary pillars to bridge the gap in public understanding and returned trust in science and research. As someone who lives with a chronic illness and grew up impoverished, I recognize how critical the positive connection is between education, health, government funding, and the public. I look forward to learning and growing alongside my fellow fellows!
Alfonso Bencomo-Alvarez, Ph.D.
St. Jude Children’s Research Hospital (Tennessee)
Mayassa Bou-Dargham, Ph.D.
University of Pennsylvania
Cherry Cheuk Lam Cheung, M.Sc., Ph.D.
Indiana University School of Medicine
Elizabeth Delery, Ph.D.
Marian University (Indiana)
Jordan Holl, Ph.D.
Wadsworth New York State Department of Health
Marisa Joldrichsen, Ph.D.
The Ohio State University
Ian Saunders, Ph.D.
Johnson & Johnson (Pennsylvania)
Allison Seeger, Ph.D.
University of Texas at Austin
Tulika Singh, Ph.D.
University of California, Berkeley
Sheetal Verma, Ph.D.
Rutgers University - New Jersey Medical School
Mark Brimble, Ph.D.
St. Jude Children’s Research Hospital
Brennah Britten, Ph.D.
The Wistar Institute
Douglas Chung, Ph.D.
Genentech
David Constant, Ph.D.
Oregon Health & Science University
Neha Dubey, Ph.D.
Washington University in St. Louis
Patricia Ferrer Castillo, Ph.D.
Uniformed Services University of the Health Sciences
Henry M. Jackson Foundation for the Advancement of Military Medicine
Rebekah Kendall, Ph.D.
The University of Montana
Jillian L. McCool, Ph.D.
Lawrence Livermore National Lab
Gianluca Veggiani, Ph.D.
Louisiana State University
Insha Zahoor, Ph.D. Henry Ford Health
Mafalda de Arr谩bida Farelo, Ph.D.
City of Hope
Heather Gustafson, Ph.D.
Seattle Children's Research Institute
Anne Hahn, Ph.D.
Yale School of Public Health
Emma Hornick, Ph.D.
University of Iowa
Nicholas Maurice, Ph.D.
University of Minnesota
Srinivasu Mudalagiriyappa, D.V.M., Ph.D.
Amgen
Amali Samarasinghe, Ph.D.
University of Tennessee Health Sciences Center
Derek Theisen, Ph.D.
Washington University in St. Louis
Sarah Webster, Ph.D.
Western Michigan University Homer Stryker M.D. School of Medicine
Samantha Yeligar, Ph.D.
Emory University
Adeleye Adeshakin, Ph.D.
St. Jude Children’s Research Hospital
Adriana Benavides, Ph.D.
American Association for Cancer Research
Jeremy Crawford, Ph.D.
St. Jude Children’s Research Hospital
Caroline Jones, Ph.D.
University of Texas at Dallas
Jamie McCall, Ph.D.
West Virginia University
Chandra Menendez, Ph.D.
University of Oklahoma Health Sciences Center
Victoria Mutua, D.V.M., Ph.D.
University of California, Davis
Ninecia Scott, Ph.D.
Centers for Disease Control and Prevention
Erin Taylor, Ph.D.
University of Mississippi Medical Center
,
| Year |
Recipient |
Sort Name |
| 2022-2023 |
Adeleye Adeshakin, Ph.D. |
Adeshakin |
| 2022-2023 |
Adriana Benavides, Ph.D. |
Benavides |
| 2022-2023 |
Jeremy Crawford, Ph.D. |
Crawford |
| 2022-2023 |
Caroline Jones, Ph.D. |
Jones |
| 2022-2023 |
Jamie McCall, Ph.D. |
McCall |
| 2022-2023 |
Chandra Menendez, Ph.D. |
Menendez |
| 2022-2023 |
Victoria Mutua, D.V.M., Ph.D. |
Mutua |
| 2022-2023 |
Ninecia Scott, Ph.D. |
Scott |
| 2022-2023 |
Erin Taylor, Ph.D. |
Taylor |
| 2021-2022 |
Todd Bradley, Ph.D. |
Bradley |
| 2021-2022 |
Virginia Camacho, Ph.D. |
Camacho |
| 2021-2022 |
Victor Cortez, Ph.D. |
Cortez |
| 2021-2022 |
Meredith Crane, Ph.D. |
Crane |
| 2021-2022 |
Mary Fontana, Ph.D. |
Fontana |
| 2021-2022 |
Teresia Maina, Ph.D. |
Maina |
| 2021-2022 |
Cody McHale, Ph.D. |
McHale |
| 2020-2021 |
S. Elizabeth Franks, Ph.D. |
Franks |
| 2020-2021 |
Erin M. Harberts, Ph.D. |
Harberts |
| 2020-2021 |
April Huseby Kelcher, Ph.D. |
Kelcher |
| 2020-2021 |
Peter D. Krueger, Ph.D. |
Krueger |
| 2020-2021 |
Brina Lopez, D.V.M., Ph.D. |
Lopez |
| 2020-2021 |
Joshua T. Mattila, Ph.D. |
Mattila |
| 2020-2021 |
Parameswaran Ramakrishnan, Ph.D. |
Ramakrishnan |
| 2020-2021 |
Julia M. Scordo, Ph.D. |
Scordo |
| 2020-2021 |
Shipra Vaishnava, Ph.D. |
Vaishnava |
| 2020-2021 |
Tayab Waseem, Ph.D. |
Waseem |
| 2019-2020 |
Ty Crowl, Ph.D. |
Crowl |
| 2019-2020 |
Magdia De Jesus, Ph.D. |
De Jesus |
| 2019-2020 |
Nicholas Hess, Ph.D. |
Hess |
| 2019-2020 |
Rebecca Hesterberg, Ph.D. |
Hesterberg |
| 2019-2020 |
Weishan Huang, Ph.D. |
Huang |
| 2019-2020 |
Peter Morawski, Ph.D. |
Morawski |
| 2019-2020 |
Dennis Neeld, Ph.D. |
Neeld |
| 2019-2020 |
Shailbala Singh, D.V.M., Ph.D. |
Singh |
| 2019-2020 |
Anibal Valentin-Acevedo, Ph.D. |
Valentin-Acevedo |
| 2019-2020 |
Leah Wuescher, Ph.D. |
Wuescher |
| 2018-2019 |
Nathaniel H. Boyd, Ph.D. |
Boyd |
| 2018-2019 |
Gavin H. Imperato, M.D. |
Imperato |
| 2018-2019 |
Liz McMichael, Ph.D. |
McMichael |
| 2018-2019 |
Gregory Szeto, Ph.D. |
Szeto |
| 2018-2019 |
Francisco R. Victorino, Ph.D. |
Victorino |
| 2018-2019 |
Emily A. Hemann, Ph.D. |
Hemann |
| 2018-2019 |
Jesica R. Jacobs, Ph.D. |
Jacobs |
| 2018-2019 |
Mallory L. Paynich, Ph.D. |
Paynich |
| 2018-2019 |
Stina L. Urban, Ph.D. |
Urban |
| 2018-2019 |
Melody Y. Zeng, Ph.D. |
Zeng |
| 2016-2017 |
Mufadhal Al-Kuhlani, Ph.D. |
Al-Kuhlani |
| 2016-2017 |
Eyal Amiel, Ph.D. |
Amiel |
| 2013-2014 |
Rachel Bergerson, Ph.D. |
Bergerson |
| 2014-2015 |
Matthew Billard, Ph.D. |
Billard |
| 2013-2014 |
Jennifer (Lori) Blanchfield, Ph.D. |
Blanchfield |
| 2014-2015 |
C. Colin Brinkman, Ph.D. |
Brinkman |
| 2015-2016 |
Tullia Bruno, Ph.D. |
Bruno |
| 2016-2017 |
Kristina Burrack, Ph.D. |
Burrack |
| 2011-2012 |
Judy Cannon, Ph.D. |
Cannon |
| 2012-2013 |
Ling Cao, M.D., Ph.D. |
Cao |
| 2011-2012 |
Devavani Chatterjea, Ph.D. |
Chatterjea |
| 2016-2017 |
Michael Constantinides, Ph.D. |
Constantinides |
| 2016-2017 |
Stacey Cranert, Ph.D. |
Cranert |
| 2014-2015 |
Ryan Cummings, Ph.D. |
Cummings |
| 2014-2015 |
Jonathan Deane, Ph.D. |
Deane |
| 2013-2014 |
Gretchen Diehl, Ph.D. |
Diehl |
| 2015-2016 |
Jason Gigley, Ph.D. |
Gigley |
| 2012-2013 |
Kory Hallett, Ph.D. |
Hallett |
| 2015-2016 |
Nichol Holodick, Ph.D. |
Holodick |
| 2013-2014 |
Katrina Hoyer, Ph.D. |
Hoyer |
| 2011-2012 |
Shawn Jackson, Ph.D. |
Jackson |
| 2012-2013 |
Stephanie James, Ph.D. |
James |
| 2011-2012 |
Kamal Khanna, Ph.D. |
Khanna |
| 2014-2015 |
Heather Kling, Ph.D. |
Kling |
| 2015-2016 |
David Larson, Ph.D. |
Larson |
| 2013-2014 |
Elizabeth Leadbetter, Ph.D. |
Leadbetter |
| 2011-2012 |
Linda Lieberman, Ph.D. |
Lieberman |
| 2015-2016 |
Nicole Perry Lieberman, Ph.D. |
Lieberman |
| 2016-2017 |
Jacquelyn Lykken, Ph.D. |
Lykken |
| 2015-2016 |
Jean Nepomuscene Manirarora, D.V.M., Ph.D. |
Manirarora |
| 2015-2016 |
Meghan 惭补谤谤茅, Ph.D. |
惭补谤谤茅 |
| 2011-2012 |
Jeffrey Mills, Ph.D. |
Mills |
| 2011-2012 |
Amy Moran, Ph.D. |
Moran |
| 2012-2013 |
Joshua Obar, Ph.D. |
Obar |
| 2014-2015 |
Shaun O'Brien, Ph.D. |
O'Brien |
| 2014-2015 |
Karen O'Connell Martins, Ph.D. |
O'Connell Martins |
| 2011-2012 |
Anastazia Older Aguilar, Ph.D. |
Older Aguilar |
| 2012-2013 |
Hannah Phipps-Yonas, Ph.D. |
Phipps-Yonas |
| 2014-2015 |
Rebecca Pompano, Ph.D. |
Pompano |
| 2012-2013 |
Melanie Ragin, Ph.D. |
Ragin |
| 2014-2015 |
Sesquile Ramon, Ph.D. |
Ramon |
| 2016-2017 |
Srinika Ranasinghe, Ph.D. |
Ranasinghe |
| 2012-2013 |
Jillian Richmond, Ph.D. |
Richmond |
| 2012-2013 |
Mark Rubinstein, Ph.D. |
Rubinstein |
| 2013-2014 |
Surojit Sarkar, Ph.D. |
Sarkar |
| 2013-2014 |
Jeremy Schaefer, Ph.D. |
Schaefer |
| 2013-2014 |
Brian Sheridan, Ph.D. |
Sheridan |
| 2012-2013 |
Adam Soloff, Ph.D. |
Soloff |
| 2014-2015 |
Stefanie Sowinski, Ph.D. |
Sowinski |
| 2015-2016 |
Erica Stone, Ph.D. |
Stone |
| 2016-2017 |
Rachel Temple, Ph.D. |
Temple |
| 2013-2014 |
Tamisha Vaughan, Ph.D. |
Vaughan |
| 2015-2016 |
Joshua Vieth, Ph.D. |
Vieth |
| 2016-2017 |
Lavanya Visvabharathy, Ph.D. |
Visvabharathy |
| 2013-2014 |
Stephanie Watkins, Ph.D. |
Watkins |
| 2012-2013 |
Dina Weilhammer, Ph.D. |
Weilhammer |
| 2011-2012 |
Eric Weimer, Ph.D. |
Weimer |
| 2015-2016 |
Jessica Werner, Ph.D. |
Werner |
| 2011-2012 |
Caleph Wilson, Ph.D. |
Wilson |
| 2016-2017 |
Mary Young, Ph.D. |
Young |
| 2017-2018 |
Heather Marie Buechel, Ph.D. |
Buechel |
| 2017-2018 |
David J. Dowling, Ph.D. |
Dowling |
| 2017-2018 |
Mariana Guerra-Maupome, D.V.M., Ph.D. |
Guerra-Maupome |
| 2017-2018 |
Farrah C. Phillips, Ph.D. |
Phillips |
| 2017-2018 |
Rachel S. Resop, Ph.D. |
Resop |
| 2017-2018 |
Timothy Rosean, Ph.D. |
Rosean |
| 2017-2018 |
Nathaniel Schuldt, Ph.D. |
Schuldt |
| 2017-2018 |
Julie Swartzendruber, Ph.D. |
Swartzendruber |
| 2017-2018 |
Melissa M. Walker, Ph.D. |
Walker |
| 2017-2018 |
Spencer C. Wei, Ph.D. |
Wei |